Stock Scorer

Polomar Health Services, Inc. (PMHS)

Polomar Health Services, Inc. reported revenue of 1.5M USD for the quarter ending 30 June 2026, up 27847.1% from 5.5K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 1.5M +27847.1%
Gross Profit Q2 '26 · ending 30 June 2026 935.9K +24323.7%
Operating Income Q2 '26 · ending 30 June 2026 218.4K —
Net Income Q2 '26 · ending 30 June 2026 200.4K —
Cost of Revenue Q2 '26 · ending 30 June 2026 592.8K +36089.8%
Operating Cash Flow Q2 '26 · ending 30 June 2026 121.3K —
Free Cash Flow Q4 '24 · ending 31 December 2024 -315K —
Shares Outstanding Q2 '26 · ending 30 June 2026 28.1M +1.4%
EPS Q2 '26 · ending 30 June 2026 -0.35 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 648.2K-10.6M-10.7M—
20242024-12-31 58.8K-1.3M-1.3M-1.1M
20232023-12-31 41.8K-440.8K-588K—
20222022-12-31 34.5K-181.5K-181.1K—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-301.5M
Q1 '262026-03-311M
Q4 '252025-12-31632.1K
Q3 '252025-09-306.2K
Q2 '252025-06-305.5K
Q1 '252025-03-314.5K
Q4 '242024-12-3120.9K
Q3 '242024-09-309.8K
Q2 '242024-06-3014.5K
Q1 '242024-03-3113.6K
Q4 '232023-12-3117.3K
Q3 '232023-09-3021.5K
Q4 '222022-12-3130K
Q3 '222022-09-304.5K

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30935.9K
Q1 '262026-03-31550.5K
Q4 '252025-12-31448.8K
Q3 '252025-09-304.3K
Q2 '252025-06-303.8K
Q1 '252025-03-313.2K
Q4 '242024-12-319.1K
Q3 '242024-09-308.9K
Q2 '242024-06-3010.3K
Q1 '242024-03-312.7K
Q4 '232023-12-3115.1K
Q3 '232023-09-3019.9K
Q4 '222022-12-3130K
Q3 '222022-09-304.5K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30218.4K
Q1 '262026-03-31-6.9K
Q4 '252025-12-31-8.9M
Q3 '252025-09-30-628.8K
Q2 '252025-06-30-563.3K
Q1 '252025-03-31-415.4K
Q4 '242024-12-31-689.1K
Q3 '242024-09-30-259.2K
Q2 '242024-06-30-190.7K
Q1 '242024-03-31-160.5K
Q4 '232023-12-31-94.5K
Q3 '232023-09-30-134.7K
Q2 '232023-06-30-91K
Q1 '232023-03-31-89.8K
Q4 '222022-12-31-152K
Q3 '222022-09-30-13.5K
Q2 '222022-06-30-13.7K
Q1 '222022-03-31-2.2K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30200.4K
Q1 '262026-03-31-25.4K
Q4 '252025-12-31-9M
Q3 '252025-09-30-649.8K
Q2 '252025-06-30-605.6K
Q1 '252025-03-31-456.9K
Q4 '242024-12-31-718.8K
Q3 '242024-09-30-271.3K
Q2 '242024-06-30-190.7K
Q1 '242024-03-31-160.5K
Q4 '232023-12-31-127.6K
Q3 '232023-09-30-172.2K
Q2 '232023-06-30-91K
Q1 '232023-03-31-89.8K
Q4 '222022-12-31-151.7K
Q3 '222022-09-30-13.4K
Q2 '222022-06-30-13.7K
Q1 '222022-03-31-2.2K

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30592.8K
Q1 '262026-03-31455K
Q4 '252025-12-31183.3K
Q3 '252025-09-301.8K
Q2 '252025-06-301.6K
Q1 '252025-03-311.4K
Q4 '242024-12-3111.8K
Q3 '242024-09-30985
Q2 '242024-06-304.2K
Q1 '242024-03-3110.9K
Q4 '232023-12-312.2K
Q3 '232023-09-301.5K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30121.3K
Q1 '262026-03-3134.4K
Q4 '252025-12-31190K
Q3 '252025-09-30-352.7K
Q2 '252025-06-30-187.8K
Q1 '252025-03-31-45.6K
Q4 '242024-12-31-315K
Q3 '242024-09-30-292.1K
Q2 '242024-06-30-247.9K
Q1 '242024-03-31-164.8K
Q4 '232023-12-31-220.1K
Q3 '232023-09-30-149.7K
Q2 '232023-06-30-91.4K
Q1 '232023-03-31-73K
Q4 '222022-12-31-15.6K
Q3 '222022-09-30-13.1K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '242024-12-31-315K
Q3 '242024-09-30-302.8K
Q2 '242024-06-30-286.7K
Q1 '242024-03-31-206.2K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3028.1M
Q1 '262026-03-3128M
Q3 '252025-09-3028M
Q2 '252025-06-3027.7M
Q1 '252025-03-3127.7M
Q3 '242024-09-3027.7M
Q2 '242024-06-3027.7M
Q1 '242024-03-3127.7M
Q3 '232023-09-3027.7M
Q2 '232023-06-30108.6M
Q1 '232023-03-31108.5M
Q3 '222022-09-30266.2K
Q2 '222022-06-30313.6K

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.35
Q1 '262026-03-31-0.37
Q4 '252025-12-31-0.39
Q3 '252025-09-30-0.09
Q2 '252025-06-30-0.08
Q1 '252025-03-31-0.07
Q4 '242024-12-31-0.06
Q3 '242024-09-30-0.04
Q2 '242024-06-30-0.04
Q1 '242024-03-31-0.03
Q4 '232023-12-31-0.02